A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate

International Journal of Pharmaceutics

Volumn 455, Issue 1-2, 2013, Pages 75-84

  Li, Jing ^a   Wu, Lin ^a   Wu, Weijun ^a   Wang, Baoyan ^a   Wang, Zhongyuan ^a   Xin, Hongliang ^a   Xu, Qunwei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Corneal permeability; Glycerol monooleate; Liquid crystal nanoparticle; Pilocarpine nitrate; Reverse hexagonal phase

Indexed keywords

DRUG CARRIER; GLYCEROL OLEATE; NANOPARTICLE; PILOCARPINE; POLOXAMER;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISPERSION; INTRAOCULAR PRESSURE; LIQUID CRYSTAL; NANOENCAPSULATION; NONHUMAN; OSMOTIC PRESSURE; PARTICLE SIZE; PH; PRIORITY JOURNAL; RABBIT; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

CORNEAL PERMEABILITY; GLYCEROL MONOOLEATE; LIQUID CRYSTAL NANOPARTICLE; PILOCARPINE NITRATE; REVERSE HEXAGONAL PHASE;

ADMINISTRATION, OPHTHALMIC; ANIMALS; CORNEA; DRUG CARRIERS; GLYCERIDES; INTRAOCULAR PRESSURE; LIQUID CRYSTALS; MIOTICS; NANOPARTICLES; OPHTHALMIC SOLUTIONS; PERMEABILITY; PILOCARPINE; POLOXAMER; RABBITS;

EID: 84883870236     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.07.057     Document Type: Article

References (44)

1. Akman, A., Cetinkaya, A., Akova, Y.A., Ertan, A., 2004. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination. Eye 19, 145-151.
2. Amar-Yuli, I., Wachtel, E., Shoshan, E.B., Danino, D., Aserin, A., Garti, N., 2007. Hexosome and hexagonal phases mediated by hydration and polymeric stabilizer. Langmuir 23, 3637-3645. (Pubitemid 46581888)
3. Anumolu, S.N.S., Singh, Y., Gao, D., Stein, S., Sinko, P.J., 2009. Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response. J. Control. Release 137, 152-159.
4. Bansal, S., Kashyap, C.P., Aggarwal, G., Harikumar, S.L., 2012. A comparative review on vesicular drug delivery system and stability issues. I. J. R. P. C. 2 (3), 704-713.
5. Barauskas, J., Cervin, C., Jankunec, M., Špandyreva, M., Ribokaitė, K., Tiberg, F., Johnsson, M., 2010. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. Int. J. Pharm. 391, 284-291.
6. Boyd, B.J., Whittaker, D.V., Khoo, S.M., Davey, G., 2006. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int. J. Pharm. 309, 218-226. (Pubitemid 43129485)
7. Chung, H., Kim, J., Um, J.Y., Kwon, I.C., Jeong, S.Y., 2002. Self-assembled "nanocubicle" as a carrier for peroral insulin delivery. Diabetologia 45, 448-451. (Pubitemid 34267369)
8. de Campo, L., Yaghmur, A., Sagalowicz, L., Leser, M.E., Watzke, H., Glatter, O., 2004. Reversible phase transitions in emulsified nanostructured lipid systems. Langmuir 20, 5254-5261.
9. Desai, S.D., Blanchard, J., 2000. Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine. Drug Deliv. 7, 201-207. (Pubitemid 32057551)
10. Draize, J.H., Woodard, G., Calvery, H.O., 1944a. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 82, 377-390.
11. Draize, J.H., Woodard, G., Calvery, H.O., 1944b. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 82, 377-390.
12. Drummond, C.J., Fong, C., 1999. Surfactant self-assembly objects as novel drug delivery vehicles. Curr. Opin. Colloid Interface Sci. 4, 449-456. (Pubitemid 30449773)
13. Fong, W.K., Hanley, T., Boyd, B.J., 2009. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo. J. Control. Release 135, 218-226.
14. Gan, L., Han, S., Shen, J., Zhu, J., Zhu, C., Zhang, X., Gan, Y., 2010. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int. J. Pharm. 396, 179-187.
15. Gavini, E., Chetoni, P., Cossu, M., Alvarez, M.G., Saettone, M.F., Giunchedi, P., 2004. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur. J. Pharm. Biopharm. 57, 207-212. (Pubitemid 38283696)
16. Guo, C., Wang, J., Cao, F., Lee, R.J., Zhai, G., 2010. Lyotropic liquid crystal systems in drug delivery. Drug Discovery Today 15, 1032-1040.
17. Hyde, S.T., Andersson, S., Ericsson, B., Larsson, K., 1984. A cubic structure consisting of a lipid bilayer forming an infinite periodic minimum surface of the gyroid type in the glycerolmonooleat-water system. Z. Kristallogr. 168, 213-219.
18. Ibrahim, H.K., El-Leithy, I.S., Makky, A.A., 2010. Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy. Mol. Pharmacol. 7, 576-585.
19. Johnsson, M., Barauskas, J., Norlin, A., Tiberg, F., 2006. Physicochemical and drug delivery aspects of lipid-based liquid crystalline nanoparticles: a case study of intravenously administered propofol. J. Nanosci. Nanotechnol. 6, 9-10.
20. Kassem, M.A., Abdel, R.A., Ghorab, M.M., Ahmed, M.B., Khalil, R.M., 2007. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int. J. Pharm. 340, 126-133. (Pubitemid 47043351)
21. Law, S.L., Huang, K.J., Chiang, C.H., 2000. Acyclovir-containing liposomes for potential ocular delivery: corneal penetration and absorption. J. Control. Release 63, 135-140. (Pubitemid 30046949)
22. Li, N., Zhuang, C., Wang, M., Sun, X., Nie, S., Pan, W., 2009. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int. J. Pharm. 379, 131-138.
23. Libster, D., Ishai, P.B., Aserin, A., Shoham, G., Garti, N., 2009. Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A. Int. J. Pharm. 367, 115-126.
24. Lopes, L.B., Ferreira, D.A., de Paula, D., Garcia, M.T., Thomazini, J.A., Fantini, M.C., Bentley, M.V., 2006. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm. Res. 23, 1332-1342. (Pubitemid 43946155)
25. Miller, S.C., Donovan, M.D., 1982. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int. J. Pharm. 12, 147-152. (Pubitemid 12037338)
26. Mitra, A.K., Mikkelson, T.J., 1988. Mechanism of transcorneal permeation of pilocarpine. J. Pharm. Sci.-Us 77, 771-775.
27. Monduzzi, M., Ljusberg-Wahren, H., Larsson, K., 2000. A 13C NMR study of aqueous dispersions of reversed lipid phases. Langmuir 16, 7355-7358.
28. Mulet, X., Boyd, B.J., Drummond, C.J., 2013. Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions. J. Colloid Interface Sci. 393, 1-20.
29. Nagarwal, R.C., Kant, S., Singh, P.N., Maiti, P., Pandit, J.K., 2009. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J. Control. Release 136, 2-13.
30. Nair, K.L., Vidyanand, S., James, J., Kumar, G.S., 2012. Pilocarpine-loaded poly (DL-lactic-co-glycolic acid) nanoparticles as potential candidates for controlled drug delivery with enhanced ocular pharmacological response. J. Appl. Polym. Sci. 124 (3), 2030-2036.
31. Narurkar, M.M., Mitra, A.K., 1989. Prodrugs of 5-iodo-2′- deoxyuridine for enhanced ocular transport. Pharm. Res. 6, 887-891. (Pubitemid 20012243)
32. Quigley, H.A., Broman, A.T., 2006. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262-267. (Pubitemid 43325451)
33. Saettone, M.F., Chetoni, P., Cerbai, R., Mazzanti, G., Braghiroli, L., 1996. Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four β-blockers, and in vitro/in vivo toxic activity. Int. J. Pharm. 142, 103-113. (Pubitemid 26343835)
34. Shell, J.W., 1984. Ophthalmic drug delivery systems. Surv. Ophthalmol. 29, 117-128. (Pubitemid 15203566)
35. Sieg, J.W., Robinson, J.R., 1979. Vehicle effects on ocular drug bioavailability III: shear-facilitated pilocarpine release from ointments. J. Pharm. Sci. 68, 724-728. (Pubitemid 9214381)
36. Suhonen, P., Jarvinen, T., Peura, P., Urtti, A., 1991. Permeability of pilocarpic acid diesters across albino rabbit cornea in vitro. Int. J. Pharm. 74, 221-228.
37. Taskovich, L.T., 1989. Skin permeation enhancer compositions using glycerol monooleate. Google Patents.
38. Thadanki, M., Srivalli, P., Prabha, K., 2011. Overview of cubosomes: a nano particle. Int. J. Res. Pharm. Chem. 1, 535-541.
39. Ticho, U., Blementhal, M., Zonis, S., Gal, A., Blank, I., Mazor, Z.W., 1979. Piloplex, a new long-acting pilocarpine polymer salt. A: long-term study. Br. J. Ophthalmol. 63, 45-47. (Pubitemid 9051242)
40. Vandamme, T.F., 2002. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog. Retin. Eye Res. 21, 15-34.
41. Vandoolaeghe, P., Tiberg, F., Nylander, T., 2006. Interfacial behavior of cubic liquid crystalline nanoparticles at hydrophilic and hydrophobic surfaces. Langmuir 22, 9169-9174. (Pubitemid 44818501)
42. Yaghmur, A., Glatter, O., 2009a. Characterization and potential applications of nanostructured aqueous dispersions. Adv. Colloid Interface 147, 333-342.
43. Yaghmur, A., Glatter, O., 2009b. Characterization and potential applications of nanostructured aqueous dispersions. Adv. Colloid Interface 147, 333-342.
44. Yang, D., Armitage, B., Marder, S.R., 2004. Cubic liquid-crystalline nanoparticles. Angew. Chem. Int. Ed. 43, 4402-4409. (Pubitemid 39268845)